Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PHIO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: bullish
Last trade: buy 14 days ago
Red flags: 1
24 filers reported a long position in PHIO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| JANE STREET GROUP, LLC | $120.7K | 117.8K | -1.2% |
| GEODE CAPITAL MANAGEMENT, LLC | $117.4K | 114.6K | -22.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $96.6K | 94.3K | +18% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $51K | 50K | New |
| Cetera Investment Advisers | $48.7K | 47.5K | +5.6% |
| CITADEL ADVISORS LLC | $48.3K | 47.2K | New |
| VANGUARD FIDUCIARY TRUST CO | $39.1K | 38.2K | Unchanged |
| NORTHERN TRUST CORP | $28.5K | 27.8K | +16.9% |
| TWO SIGMA INVESTMENTS, LP | $22K | 21.5K | -33.8% |
| XTX Topco Ltd | $18.9K | 18.5K | -25.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.